These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34593251)

  • 1. Antithymocyte Globulin Treatment for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Experience From a National Reference Transplant Center.
    Margallo Iribarnegaray J; De Pablo Gafas A; Alonso Moralejo R; Quezada Loaiza CA; Revuelta Salgado F; Pina Maíquez I; Pérez González VL
    Transplant Proc; 2021 Nov; 53(9):2710-2717. PubMed ID: 34593251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Rabbit Antithymocyte Globulin in Chronic Lung Allograft Dysfunction.
    Izhakian S; Wasser WG; Fox BD; Vainshelboim B; Reznik JE; Kramer MR
    Transplant Proc; 2016; 48(6):2152-6. PubMed ID: 27569962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
    J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction.
    January SE; Fester KA; Bain KB; Kulkarni HS; Witt CA; Byers DE; Alexander-Brett J; Trulock EP; Hachem RR
    Clin Transplant; 2019 Oct; 33(10):e13708. PubMed ID: 31494969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
    Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
    Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction.
    Kotecha S; Paul E; Ivulich S; Fuller J; Paraskeva M; Levvey B; Snell G; Westall G
    Transplant Direct; 2021 Apr; 7(4):e681. PubMed ID: 33748410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal infection and colonization in lung transplant recipients with chronic lung allograft dysfunction.
    Pennington KM; Aversa M; Martinu T; Johnson B; Husain S
    Transpl Infect Dis; 2022 Dec; 24(6):e13986. PubMed ID: 36380578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients.
    Kao JE; Zirbes JM; Conrad CK; Milla CE
    J Heart Lung Transplant; 2017 Sep; 36(9):980-984. PubMed ID: 28651906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
    Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
    Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA; Huber L; Murer C; Schuurmans M; Kohler M; Hofbauer G; Benden C
    Swiss Med Wkly; 2017; 147():w14429. PubMed ID: 28488260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.
    Benazzo A; Schwarz S; Muckenhuber M; Schweiger T; Muraközy G; Moser B; Sigüenza JM; Lang G; Taghavi S; Klepetko W; Hoetzenecker K; Jaksch P; Lambers C
    PLoS One; 2019; 14(1):e0210443. PubMed ID: 30645645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Metapneumovirus and Parainfluenza Virus Infections in Lung Transplant Recipients: The Effects on Lung Allograft and Clinical Outcomes.
    Permpalung N; Sait AS; Bazemore K; Avery RK; Mathew J; Shah PD
    Transplantation; 2021 Dec; 105(12):2625-2631. PubMed ID: 33496558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States.
    Sheshadri A; Sacks NC; Healey B; Cyr P; Boerner G; Huang HJ
    J Med Econ; 2022; 25(1):650-659. PubMed ID: 35502563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
    Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
    J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.